Skip to main content
British Journal of Cancer logoLink to British Journal of Cancer
. 1989 May;59(5):772–774. doi: 10.1038/bjc.1989.161

Assessment of bone marrow infiltration in B-cell non-Hodgkin's lymphoma (NHL).

E L Dorey 1, S V Outram 1, A Holder 1, A Z Rohatiner 1, F E Cotter 1, M Deane 1, A G Stansfeld 1, T A Lister 1, M A Horton 1
PMCID: PMC2247209  PMID: 2472166

Full text

PDF
772

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson K. C., Bates M. P., Slaughenhoupt B. L., Pinkus G. S., Schlossman S. F., Nadler L. M. Expression of human B cell-associated antigens on leukemias and lymphomas: a model of human B cell differentiation. Blood. 1984 Jun;63(6):1424–1433. [PubMed] [Google Scholar]
  2. Bast R. C., Jr, De Fabritiis P., Lipton J., Gelber R., Maver C., Nadler L., Sallan S., Ritz J. Elimination of malignant clonogenic cells from human bone marrow using multiple monoclonal antibodies and complement. Cancer Res. 1985 Feb;45(2):499–503. [PubMed] [Google Scholar]
  3. Benjamin D., Magrath I. T., Douglass E. C., Corash L. M. Derivation of lymphoma cell lines from microscopically normal bone marrow in patients with undifferentiated lymphomas: evidence of occult bone marrow involvement. Blood. 1983 May;61(5):1017–1019. [PubMed] [Google Scholar]
  4. Brada M., Mizutani S., Molgaard H., Sloane J. P., Treleaven J., Horwich A., Peckham M. J. Circulating lymphoma cells in patients with B & T non-Hodgkin's lymphoma detected by immunoglobulin and T-cell receptor gene rearrangement. Br J Cancer. 1987 Aug;56(2):147–152. doi: 10.1038/bjc.1987.174. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Clark P., Normansell D. E., Innes D. J., Hess C. E. Lymphocyte subsets in normal bone marrow. Blood. 1986 Jun;67(6):1600–1606. [PubMed] [Google Scholar]
  6. Nadler L. M., Takvorian T., Botnick L., Bast R. C., Finberg R., Hellman S., Canellos G. P., Schlossman S. F. Anti-B1 monoclonal antibody and complement treatment in autologous bone-marrow transplantation for relapsed B-cell non-Hodgkin's lymphoma. Lancet. 1984 Aug 25;2(8400):427–431. doi: 10.1016/s0140-6736(84)92907-6. [DOI] [PubMed] [Google Scholar]
  7. Stashenko P., Nadler L. M., Hardy R., Schlossman S. F. Characterization of a human B lymphocyte-specific antigen. J Immunol. 1980 Oct;125(4):1678–1685. [PubMed] [Google Scholar]
  8. Stashenko P., Nadler L. M., Hardy R., Schlossman S. F. Expression of cell surface markers after human B lymphocyte activation. Proc Natl Acad Sci U S A. 1981 Jun;78(6):3848–3852. doi: 10.1073/pnas.78.6.3848. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Weiss L. M., Warnke R. A., Sklar J., Cleary M. L. Molecular analysis of the t(14;18) chromosomal translocation in malignant lymphomas. N Engl J Med. 1987 Nov 5;317(19):1185–1189. doi: 10.1056/NEJM198711053171904. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES